Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Cotinga Pharmaceuticals (Canada)
Alternate names:
Cotinga Pharmaceuticals,
Cotinga Pharmaceuticals Inc.,
Critical Outcome Technologies Inc.
ROR:
05e4sws69
OpenAlex ID:
I4405273188
COTI-2, a novel small molecule that is active against multiple human cancer cell linesin vitroandin vivo
2016
·
Kowthar Y. Salim
, Saman Maleki Vareki
, et al.
·
Oncotarget
·
155
PDF
Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines
2018
·
Saman Maleki Vareki
, Kowthar Y. Salim
, et al.
·
PLoS ONE
·
46
PDF
Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
2017
·
Kowthar Y. Salim
, Saman Maleki Vareki
, et al.
·
Oncotarget
·
5
PDF
COTI-2, a potent orally available small molecule targeting mutant p53, with promising efficacy as monotherapy and combination treatment in preclinical tumor models.
2018
·
Richard T Ho
, Kowthar Y Salim
, et al.
·
Journal of Clinical Oncology
·
4
Piecewise-Affine Approximations for a Powertrain Control Verification Benchmark
2018
·
Jyotirmoy Deshmukh
, Hisahiro Ito
, et al.
·
EPiC series in computing
·
1
PDF
Abstract A25: COTI-2, a novel small molecule that is effective against multiple human cancer cell lines in vitro and in vivo
2017
·
Kowthar Y. Salim
, Saman Maleki Vareki
, et al.
·
Clinical Cancer Research
·
1
The Novel Thiosemicarbazone Derivative Coti-2 Induces Mitochondrial Apoptosis in Acute Myeloid Leukemia Cells Via a p53-Independent Mechanism
2016
·
Dhruv Chachad
, Jo Ishizawa
, et al.
·
Blood
The basic polynomial algebra subprograms
2016
·
Changbo Chen
, Svyatoslav Covanov
, et al.
·
ACM communications in computer algebra
PDF
Show more works
View as search
Works count:
8
Citation count:
419
Year
Topic
Type
